Phakic implantable collamer lens implantation for correcting low-to-moderate myopia
10.3980/j.issn.1672-5123.2024.10.28
- VernacularTitle:有晶状体眼后房型人工晶状体植入术矫正中低度近视
- Author:
Jiayu CAI
1
;
Jian CHEN
1
;
Yong LI
1
;
Fen GUI
1
;
Xiang WU
1
Author Information
1. Department of Refractive Surgery, Xiaogan Aier Eye Hospital, Xiaogan 432000, Hubei Province, China
- Publication Type:Journal Article
- Keywords:
phakic implantable collamer lens implantation;
low-to-moderate myopia;
vault;
safety;
efficacy;
refractive surgery
- From:
International Eye Science
2024;24(10):1668-1671
- CountryChina
- Language:Chinese
-
Abstract:
AIM:To investigate the clinical efficacy of phakic implantable collamer lens(ICL)implantation in correcting low-to-moderate myopia.METHODS: Retrospective study. A total of 48 patients(85 eyes)with low to moderate myopia who underwent ICL implantation were included in the study. The changes in uncorrected visual acuity(LogMAR), corrected visual acuity(LogMAR), refractive outcomes, intraocular pressure, vault and endothelial cell were observed at 1 a postoperatively.RESULTS: At 12 mo postoperatively, uncorrected and best-corrected visual acuity were -0.10(-0.20, -0.10)and -0.10(-0.20, -0.10), respectively, with an efficacy index of 1.07±0.13 and a safe index of 1.10±0.14. The difference between the actual corrected diopter and the expected corrected diopter was 91%(77/85)in the range of ±0.50 D, and 100%(85/85)in the range of ±1.00 D. The mean vault was 501.16±210.46 μm at 12 mo postoperatively. There was no significant difference in corneal endothelial cell density between preoperative and 6 and 12 mo postoperatively(F=1.050, P=0.352). All patients had no anterior subcapsular opacification, cataract, pupillary block, or other sight threatening complications during follow-up.CONCLUSION: ICL implantation for the correction of low to moderate myopia has good efficacy, safety and predictability.
